Patients with ulcerative colitis, a chronic inflammatory bowel disease, often relapse at times of stress. In a clinical trial of 77 ulcerative colitis patients who were in clinical remission but were experiencing reduced ...
Apr 5, 2017
0
1
Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ...
Mar 22, 2017
0
5
Beneficial bacteria may be the key to helping to reverse a cycle of gut inflammation seen in certain inflammatory bowel diseases, University of North Carolina Lineberger Comprehensive Cancer Center researchers have found.
Mar 13, 2017
1
183
.jpg)
Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab (which targets tumour necrosis factor alpha), but at considerable cost. A recent analysis ...
Mar 3, 2017
0
3
New research indicates that the incidence of inflammatory bowel disease—including ulcerative colitis (UC) and Crohn's disease (CD)—in Denmark is on the rise and is among the highest in the world.
Feb 23, 2017
0
0
A new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has found that lower levels of vitamin D in the blood increase the risk of clinical relapse in patients with Ulcerative Colitis (UC), an inflammatory ...
Feb 17, 2017
0
3
(HealthDay)—For patients with ulcerative colitis (UC), serum vitamin D levels ≤35 ng/mL are associated with increased risk of clinical relapse, according to a study published in the February issue of Clinical Gastroenterology ...
Feb 1, 2017
0
2
UT Southwestern Medical Center researchers have identified a gene that protects the gut from inflammatory bowel disease (IBD).
Feb 1, 2017
0
103
In two studies published today (30 January) in Nature Genetics, researchers from the Wellcome Trust Sanger Institute and their collaborators have identified a genetic variant that doubles an individual's risk of developing ...
Jan 30, 2017
0
92
For approximately 70 years, physicians have used a medication containing the active agent mesalamine to treat ulcerative colitis, but little was known about how the drug targeted the inflammatory bowel disease.
Jan 23, 2017
0
341
